CRP and COVID-19: When comparing females to males with COVID-19 (Table 1), females seem to exhibit a lower rate as the severity of the disease progresses (Group A (CRP < 6 mg/L) male 41.6%, female 58.4%), Group B (CRP < 6–30 mg/L) male 43.9%, female 56.1%, Group C (CRP < 30–100 mg/L) male 60.4%, female 39.6%, Group D (CRP > 100 mg/L) male 69.7%, female 30.3%), which is in accordance with other studies [20].